GO:0051608 histamine transport: Mechanism, Genes, Functions and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0051608 histamine transport describes the directed movement of histamine into, out of, or within cells via transporters or pores.
Vesicular monoamine transporter 2 (VMAT2/SLC18A2) packages histamine into synaptic vesicles, a key step in neuronal histamine release.
Organic cation transporters (OCT2/SLC22A2, OCT3/SLC22A3) and polyspecific transporters mediate histamine clearance in the brain.
Histamine transport is coupled to synthesis in axon terminals through a dual quality control system involving SLC18A2 and SLC10A4.
Dysregulated histamine transport is implicated in Sjogren's syndrome, gastric secretion disorders, and psychiatric conditions.
CRISPR knockout, knock-in, and overexpression models enable causal dissection of histamine transporter genes in disease.

Description

Histamine is a biogenic amine that functions as a neurotransmitter, paracrine mediator, and inflammatory signal. The Gene Ontology term GO:0051608, histamine transport, is defined as the directed movement of histamine into, out of, or within a cell, or between cells, by means of some agent such as a transporter or pore. This process is essential for controlling histamine availability at its sites of action, including synaptic clefts, gastric glands, and immune cell microenvironments. Researchers study histamine transport to understand how transmitter pools are filled, how signaling is terminated, and how transport defects contribute to disease. The molecular players include vesicular monoamine transporter 2 (VMAT2, encoded by SLC18A2), which packages histamine into secretory vesicles, and plasma membrane transporters such as organic cation transporters (OCTs) that clear extracellular histamine. In axon terminals, histamine synthesis and transport are functionally coupled through a dual quality control system that ensures proper vesicular loading. In peripheral tissues, histamine transport influences gastric acid secretion and salivary gland function, and its dysregulation has been linked to Sjogren's syndrome. In the brain, polyspecific transporters and OCTs regulate histamine clearance, with implications for arousal, cognition, and psychiatric disorders. Astrocytes also take up histamine via specific transport mechanisms, contributing to histamine homeostasis in the central nervous system. Because histamine transport sits at the intersection of neurotransmission, immunity, and gastrointestinal physiology, it is a compelling target for genetic and pharmacological studies. This article synthesizes authoritative GO annotations and verified literature to provide a research-grade overview of GO:0051608, its genes, mechanisms, disease links, and experimental models.

histamine transport At A Glance

GO ID GO:0051608
GO term histamine transport
Ontology biological_process
Synonym none
Major function Directed movement of histamine across membranes via transporters or pores
Key transporters SLC18A2 (VMAT2), SLC22A2 (OCT2), SLC22A3 (OCT3), SLC10A4
Cellular locations Synaptic vesicles, plasma membrane, astrocytes, gastric glands
Physiological roles Neurotransmission, gastric acid secretion, allergic responses, salivary gland function
Disease relevance Sjogren's syndrome, psychiatric disorders, gastric secretion abnormalities

What Is GO:0051608?

GO:0051608 histamine transport is the biological process in which histamine, a physiologically active amine released from mast cells during allergic reactions, is moved into, out of, or within a cell, or between cells, by a transporter or pore. This definition encompasses vesicular loading by VMAT2, plasma membrane uptake and efflux by organic cation transporters, and clearance mechanisms in the brain and peripheral tissues.

Why Is histamine transport Important in Cell Biology?

Histamine transport is critical because it determines the concentration and duration of histamine signaling at target sites, influencing processes as diverse as synaptic transmission, gastric acid secretion, and immune responses. Defects in histamine transport have been associated with Sjogren's syndrome, where histamine transport and metabolism are deranged in salivary glands, and with psychiatric conditions linked to altered brain histamine clearance. Understanding this process provides a foundation for therapeutic strategies targeting histamine transporters in neurology, immunology, and gastroenterology.
Controls synaptic histamine levels and thus arousal, wakefulness, and cognition.
Regulates gastric acid secretion by influencing histamine availability to parietal cells.
Modulates allergic and inflammatory responses through mast cell histamine release and clearance.
Dysregulation is linked to Sjogren's syndrome salivary gland pathology.
Organic cation transporters in the brain are implicated in psychiatric disorders.
Astrocytic histamine uptake contributes to brain histamine homeostasis.
Histamine transport affects capillary protein permeability in peripheral tissues.
Provides targets for drugs modulating histamine signaling in allergy and acid-related disorders.
Enables precise control of vesicular histamine content via VMAT2 quality control.
Serves as a model for studying biogenic amine transport and vesicular packaging.

What Happens During histamine transport?

Histamine synthesis and vesicular loading
In simple terms: Histamine is made in the cell and then packed into small bubbles called vesicles for release.
Histamine is synthesized in the cytoplasm and must be transported into synaptic vesicles for regulated release. Vesicular monoamine transporter 2 (VMAT2, SLC18A2) mediates the uptake of histamine into vesicles. In axon terminals, histamine synthesis and transport are coupled through a dual quality control system that ensures only properly synthesized histamine is loaded into vesicles. This coupling involves SLC18A2 and SLC10A4, which together maintain vesicular histamine content.
Plasma membrane uptake and efflux
In simple terms: Histamine can enter or leave cells through transporter proteins in the cell membrane.
Organic cation transporters (OCTs) such as OCT2 (SLC22A2) and OCT3 (SLC22A3) mediate the bidirectional transport of histamine across plasma membranes. These polyspecific transporters are important for histamine clearance in the brain and peripheral tissues. In astrocytes, histamine transport has been characterized kinetically, indicating specific uptake mechanisms.
Histamine clearance in the brain
In simple terms: In the brain, histamine is removed from the extracellular space by transporter proteins to stop its signal.
Histamine clearance in the brain is mediated by polyspecific transporters and organic cation transporters. These transporters regulate the duration and intensity of histamine neurotransmission. Dysfunction of these clearance mechanisms has been linked to psychiatric implications, highlighting the importance of transport in brain histamine homeostasis.
Histamine transport in peripheral tissues
In simple terms: Outside the brain, histamine transport affects stomach acid production and salivary gland function.
In the stomach, histamine transport influences gastric acid secretion by regulating histamine availability to parietal cells. In salivary glands, histamine transport and metabolism are deranged in Sjogren's syndrome, suggesting a role in glandular dysfunction. Histamine also affects capillary transport of proteins in peripheral tissues, as shown in canine hindquarters.

Key Genes Involved in GO:0051608 histamine transport

The following genes encode transporters and related proteins that directly mediate or regulate histamine transport.
GeneMajor RoleResearch Relevance
SLC18A2Vesicular monoamine transporter 2 (VMAT2); packages histamine into synaptic vesiclesTarget for studying vesicular histamine loading and release
SLC22A2Organic cation transporter 2 (OCT2); plasma membrane histamine transportMediates histamine clearance in brain and periphery
SLC22A3Organic cation transporter 3 (OCT3); polyspecific histamine transportInvolved in brain histamine clearance and psychiatric implications
SLC10A4Solute carrier family 10 member 4; coupled with SLC18A2 in quality controlPart of dual quality control system for histamine synthesis and transport
SLC18A1Vesicular monoamine transporter 1 (VMAT1); potential histamine transportMay contribute to histamine transport in endocrine cells
SLC22A1Organic cation transporter 1 (OCT1); polyspecific transportPotential role in histamine transport in liver and other tissues
SLC22A4Organic cation/carnitine transporter 1 (OCTN1)May transport histamine in specific tissues
SLC22A5Organic cation/carnitine transporter 2 (OCTN2)Potential histamine transport in kidney and brain
SLC29A1Equilibrative nucleoside transporter 1; polyspecificMay contribute to histamine transport
SLC29A2Equilibrative nucleoside transporter 2; polyspecificPotential histamine transport
SLC6A2Norepinephrine transporter; can transport histamineMay influence histamine clearance in brain
SLC6A3Dopamine transporter; can transport histaminePotential histamine transport in dopaminergic neurons
SLC6A4Serotonin transporter; can transport histamineMay modulate histamine levels in serotonergic systems
HRH1Histamine receptor H1; not a transporter but mediates responsesDownstream effector of transported histamine
HRH2Histamine receptor H2; mediates gastric acid secretionReadout for histamine transport in stomach
HDCHistidine decarboxylase; synthesizes histamineCoupling of synthesis and transport in axon terminals
MAOAMonoamine oxidase A; degrades histamineMetabolic counterpart to transport in clearance
MAOBMonoamine oxidase B; degrades histamineMetabolic counterpart to transport in clearance

How Is histamine transport Regulated?

Histamine transport is regulated at multiple levels. In axon terminals, a dual quality control system couples histamine synthesis and vesicular transport, ensuring that only properly synthesized histamine is loaded into vesicles via SLC18A2 and SLC10A4. The activity of organic cation transporters can be influenced by substrate availability and post-translational modifications, although specific regulatory mechanisms in the context of histamine transport are not fully defined. In peripheral tissues, histamine transport and metabolism are deranged in Sjogren's syndrome, suggesting disease-associated dysregulation. Additionally, histamine itself can affect capillary transport properties in a time-dependent manner, indicating feedback regulation.

histamine transport and Human Disease

GeneDisease / BiologyPotential Experimental Model
SLC18A2Psychiatric disorders, vesicular transport defectsKnockout and knock-in mouse models; patient-derived iPSCs
SLC22A2Altered brain histamine clearance, psychiatric implicationsKnockout mice; overexpression cell lines
SLC22A3Psychiatric disorders, histamine clearanceKnockout mice; point mutation models
SLC10A4Coupled quality control in histamine transportKnockout and tagged knock-in models
MAOA/MAOBSjogren's syndrome, histamine metabolismKnockout mice; salivary gland organoids
Sjogren's syndrome
In Sjogren's syndrome, histamine transport and metabolism are deranged in salivary glands, contributing to glandular dysfunction and dryness symptoms. This highlights the importance of histamine homeostasis in exocrine tissues.
Psychiatric disorders
Organic cation transporters involved in brain histamine clearance have physiological and psychiatric implications, suggesting that altered histamine transport may contribute to disorders such as depression, anxiety, or schizophrenia.
Gastric secretion disorders
Histamine transport influences gastric acid secretion, and abnormalities in this process can lead to hypersecretory or hyposecretory states. Understanding transport mechanisms may inform treatments for acid-related diseases.
Allergic and inflammatory conditions
Histamine released from mast cells during allergic reactions relies on transport mechanisms for clearance and termination of signaling. Defects in transport could prolong allergic responses.

From histamine transport-Related Genes to Experimental Models

Research QuestionSuitable Model
Does SLC18A2 mediate vesicular histamine loading?SLC18A2 knockout cell lines and mice
What is the role of SLC10A4 in histamine transport quality control?SLC10A4 knockout and tagged knock-in models
How does OCT2 (SLC22A2) affect brain histamine clearance?SLC22A2 knockout mice and overexpression cells
Does OCT3 (SLC22A3) contribute to psychiatric phenotypes?SLC22A3 point mutation and knockout models
Can histamine transport be modulated in Sjogren's syndrome?Patient-derived salivary gland cells with CRISPR KO
What is the kinetic profile of astrocytic histamine transport?Primary astrocyte cultures from knockout rats

How to Study the histamine transport Process

MethodWhat It MeasuresTypical Application
CRISPR knockoutLoss of transporter functionDetermine causal role of SLC18A2 in histamine loading
Radiolabeled uptake assayTransport kinetics and substrate specificityCharacterize OCT-mediated histamine clearance
Live-cell imagingVesicular and membrane transport dynamicsVisualize histamine packaging in neurons
RNA-seqTranscriptional changes in transportersIdentify dysregulation in Sjogren's syndrome
ProteomicsProtein expression and modificationsAssess transporter levels in disease models
ElectrophysiologyTransporter currentsStudy electrogenic transport mechanisms
Knock-in reporterTagged transporter localizationTrack SLC10A4 in quality control
OverexpressionGain-of-function effectsTest sufficiency of transporters in clearance
Genetic knockout and knockdown
CRISPR-Cas9 knockout of SLC18A2, SLC22A2, SLC22A3, or SLC10A4 in cell lines and animal models allows assessment of histamine transport function. Knockout models have been used to demonstrate the role of VMAT2 in vesicular histamine loading.
Transport assays
Radiolabeled histamine uptake assays in cultured cells or synaptosomes measure transport kinetics and substrate specificity. Such assays have characterized histamine transport in astrocytes and identified organic cation transporters.
Imaging and vesicle tracking
Fluorescent histamine analogs and vesicle markers can visualize transport in live cells. This approach helps study vesicular packaging and plasma membrane transport dynamics.
Transcriptomics and proteomics
RNA-seq and proteomics can identify expression changes in histamine transporters under disease conditions, such as in Sjogren's syndrome salivary glands.

How CRISPR Can Be Used to Study GO:0051608 histamine transport

Knockout

CRISPR knockout of histamine transporter genes such as SLC18A2, SLC22A2, SLC22A3, and SLC10A4 provides definitive loss-of-function models to test their roles in histamine transport, release, and clearance.

Point Mutation

Point mutations can mimic naturally occurring variants or disrupt key residues in transporters, allowing structure-function studies of histamine recognition and translocation.

Knock-in

Knock-in of tagged transporters (e.g., fluorescent tags) enables real-time tracking of histamine transport proteins in their native context, as demonstrated for SLC10A4 in quality control.

Overexpression

Overexpression of histamine transporters in cell lines can enhance histamine uptake or clearance, useful for studying transport capacity and drug interactions.

How EDITGENE Supports histamine transport Research

Researchers studying histamine transport-related genes often need to determine whether a candidate gene is causally involved in histamine movement, clearance, or disease phenotypes. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell and animal models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for histamine transport research.

Frequently Asked Questions About histamine transport

GO:0051608 is a Gene Ontology biological process term describing the directed movement of histamine into, out of, or within a cell, or between cells, by means of a transporter or pore.
Key genes include SLC18A2 (VMAT2), SLC22A2 (OCT2), SLC22A3 (OCT3), and SLC10A4, which mediate vesicular and plasma membrane histamine transport.
In the brain, histamine is packaged into vesicles by VMAT2 and cleared from the extracellular space by organic cation transporters and polyspecific transporters.
VMAT2 (SLC18A2) transports histamine into synaptic vesicles, a critical step for regulated histamine release.
Organic cation transporters such as OCT2 (SLC22A2) and OCT3 (SLC22A3), along with polyspecific transporters, mediate histamine clearance in the brain.
Yes, dysregulated histamine transport has been linked to Sjogren's syndrome, psychiatric disorders, and gastric secretion abnormalities.
Astrocytes take up histamine via specific transport mechanisms that have been characterized kinetically in cultured cells.
In axon terminals, histamine synthesis and transport are coupled through a dual quality control system involving SLC18A2 and SLC10A4.
Yes, CRISPR knockout, knock-in, and overexpression models enable precise dissection of histamine transporter genes and their functions.
Common models include knockout mice, cultured astrocytes, and cell lines overexpressing transporters, as well as patient-derived cells for disease studies.

Conclusion

GO:0051608 histamine transport is a fundamental biological process that controls histamine availability in neural, immune, and gastrointestinal systems. The coordinated action of vesicular transporters like VMAT2 and plasma membrane transporters such as OCT2 and OCT3 ensures proper histamine signaling and clearance. Dysregulation of these processes contributes to Sjogren's syndrome, psychiatric disorders, and gastric pathologies. Advances in CRISPR-based models and transport assays continue to unravel the molecular details of histamine transport, offering new avenues for therapeutic intervention.

References

  1. 1. Peng L et al.. 2024. Histamine synthesis and transport are coupled in axon terminals via a dual quality control system.. EMBO J 43(20):4472-4491 PMID: 39242788
  2. 2. Merickel A et al.. 1995. Transport of histamine by vesicular monoamine transporter-2.. Neuropharmacology 34(11):1543-7 PMID: 8606801
  3. 3. Schubert ML. 2014. Gastric secretion.. Curr Opin Gastroenterol 30(6):578-82 PMID: 25211241
  4. 4. Katz MA. 1986. Time dependent effects of histamine on parameters of capillary transport of protein in canine hindquarters.. Microcirc Endothelium Lymphatics 3(3-4):249-79 PMID: 3323865
  5. 5. Yoshikawa T et al.. 2017. Histamine Clearance Through Polyspecific Transporters in the Brain.. Handb Exp Pharmacol 241:173-187 PMID: 27679412
  6. 6. Naganuma F et al.. 2021. Organic Cation Transporters in Brain Histamine Clearance: Physiological and Psychiatric Implications.. Handb Exp Pharmacol 266:169-185 PMID: 33641029
  7. 7. Stegaev V et al.. 2013. Histamine transport and metabolism are deranged in salivary glands in Sjogren's syndrome.. Rheumatology (Oxford) 52(9):1599-608 PMID: 23709238
  8. 8. Perdan-Pirkmajer K et al.. 2012. Molecular and kinetic characterization of histamine transport into adult rat cultured astrocytes.. Neurochem Int 61(3):415-22 PMID: 22584475
Contact Us
*
*
*
*
How did you hear about us: